Literature DB >> 1272382

Augmentation of human monocyte chemotactic response by levamisole.

M C Pike, R Snyderman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1272382     DOI: 10.1038/261136a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

Review 1.  Levamisole: a review and some observations in its effects on immunocompetence in protein-energy malnutrition and old age.

Authors:  J E Chandrashekar; R K Chandra
Journal:  Indian J Pediatr       Date:  1979-05       Impact factor: 1.967

2.  Dephosphorylation of endotoxin by alkaline phosphatase in vivo.

Authors:  K Poelstra; W W Bakker; P A Klok; J A Kamps; M J Hardonk; D K Meijer
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 3.  Chirality. Clinical pharmacokinetic and pharmacodynamic considerations.

Authors:  E J Lee; K M Williams
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

Review 4.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

5.  The in vitro evaluation of certain neutrophil and lymphocyte functions following the ingestion of 150 mg oral dose of levamisole: assessment of the extent and duration of stimulation of neutrophil chemotaxis, protein iodination and lymphocyte transformation.

Authors:  R Anderson; R Oosthuizen; A Theron; A J Van Rensburg
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

6.  The reversal of surgically induced reticuloendothelial depression.

Authors:  N W Everson; R L Stacey; R F Wood; P R Bell
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

7.  Human monocyte-lymphocyte interaction and its enhancement by levamisole.

Authors:  J W Kazura; W Negendank; D Guerry; A D Schreiber
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

8.  Alveolar macrophage-lymphocyte rosette formation: failure of levamisole to alter activity.

Authors:  R L Ziprin; S R Fowler; D A Witzel
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

9.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  The effects of D-pencillamine and levamisole on leucocyte chemotaxis in the rat.

Authors:  F M Cunningham; A W Ford-Hutchinson; A M Oliver; M J Smith; J R Walker
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.